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Background. p16
INK4a tumor suppressor protein has been widely proposed to mediate entrance of the cells into the senescent
stage. Promoter of p16
INK4a gene contains at least five putative GC boxes, named GC-I to V, respectively. Our previous data
showed that a potential Sp1 binding site, within the promoter region from 2466 to 2451, acts as a positive transcription
regulatory element. These results led us to examine how Sp1 and/or Sp3 act on these GC boxes during aging in cultured
human diploid fibroblasts. Methodology/Principal Findings. Mutagenesis studies revealed that GC-I, II and IV, especially GC-
II, are essential for p16
INK4a gene expression in senescent cells. Electrophoretic mobility shift assays (EMSA) and ChIP assays
demonstrated that both Sp1 and Sp3 bind to these elements and the binding activity is enhanced in senescent cells. Ectopic
overexpression of Sp1, but not Sp3, induced the transcription of p16
INK4a. Both Sp1 RNAi and Mithramycin, a DNA intercalating
agent that interferes with Sp1 and Sp3 binding activities, reduced p16
INK4a gene expression. In addition, the enhanced binding
of Sp1 to p16
INK4a promoter during cellular senescence appeared to be the result of increased Sp1 binding affinity, not an
alteration in Sp1 protein level. Conclusions/Significance. All these results suggest that GC- II is the key site for Sp1 binding
and increase of Sp1 binding activity rather than protein levels contributes to the induction of p16
INK4a expression during cell
aging.
Citation: Wu J, Xue L, Weng M, Sun Y, Zhang Z, et al (2007) Sp1 Is Essential for p16
INK4a Expression in Human Diploid Fibroblasts during
Senescence. PLoS ONE 2(1): e164. doi:10.1371/journal.pone.0000164
INTRODUCTION
Normal human cells undergo a finite number of cell divisions and
ultimately enter a nondividing state called replicative senes-
cence[1]. Replicative or cellular senescence was observed and
proposed as an experimental model for aging at the cellular level
over thirty years ago. Senescent cells remain metabolically active
and show characteristic changes in cell morphology, physiology
and gene expression [2–4]. The mechanism of aging is very
complex and it implicates genetics, environment, psychology and
sociology, while the genetic factor is critical for life span. There
are several independent pathways that control the process of
replicative senescence in human cells [5–9]. Such pathways often
involve the activation of the cell cycle inhibitors, p21
CIP1/WAF1
[10–12] and p16
INK4a [13–18], which are likely the genes that act
to induce cellular senescence, and are in fact direct targets of the
genetic program that leads cells to senescence [19,20].
It is well known that p16
INK4a inhibits cdk (cyclin-dependent
kinase)4/cdk6-mediated phosphorylation of retinoblastoma gene
product (pRb) and induces cell cycle arrest in G1 phase [21],
p16
INK4a up-regulation is also a key event in the terminal stages
of growth arrest in senescence. The mechanism of increased
p16
INK4a expression in senescent cells is not well understood. We
and others previously reported that some regulatory factors, such
as Bmi-1, Ets, Id1, E47, Jun B, p21
CIP1/WAF1and ITSE binding
factor, were involved in p16
INK4a transcription[22–27]. Here we
show that transcription factor Sp1 also plays an important role in
the regulation of p16
INK4a gene expression during senescence. The
increase of Sp1 binding activity rather than the protein level in
senescent fibroblasts contributes to the high levels of p16
INK4a
expression during the progress of aging. What’s more, the basal
level of Sp1 is essential for this effect.
MATERIALS AND METHODS
Cell culture
Human embryonic lung fibroblast cell line (2BS cells) obtained
from the National Institute of Biological Products (Beijing, China),
was cultured in DMEM medium, containing 10% fetal bovine
serum, 100 U/ml penicillin and 1 mg/ml streptomycin[28,29].
Plasmids construction
To make pGL3-620, 620bp 59-fragment of human p16INK4a
promoter was digested with Rsa I and Hind III from pSIR-870-
EGFP, and inserted into pGL3-Basic Luciferase Report Vector
(Promega). Site-directed mutagenesis was conducted using Quick-
change
TM Site-directed mutagenesis Kit (Stratagene) according
to the manufacturer’s protocol. Five oligo nucleotides carrying
mismatched bases: 59-GGAAGGAAACGGatCcGGGGCGGAT-
TTC-39,5 9-GGCGGGGGCaGATcTCTTTTTAACAGAG-39,
59-GGGAGGCCGGAtccCGGTGTGGGGGG-39,5 9-CAGAG-
GGTGGGGgGatCCGAGTGCGCTC-39 and 59-GCAGGCAG-
CGGGatcCGGGGAGCAGC-39 were used to mutagenize the
segments containing GC boxes spanning from nt (nucleotide)
2474 to 2447, 2462 to 2435, 2380 to 2355, 276 to 249 and
226 to 21 upstream of translational start site respectively
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confirmed by sequencing. Expression plasmids of Sp1 and Sp3
were kindly provided by Dr. Robert Tjian (University of
California, Berkeley, CA) and Dr. G. Suske (IMT, Marburg,
Germany) respectively. The pCMV plasmid without an insert
served as the control.
Transfection and luciferase activity assays
All plasmids were purified with Qiagen Plasmid Midi Kits
(Chatsworth, CA). For each transfection experiment, 2BS cells
were seeded at 12-well plates and grown for about 24 h until they
were above 90% confluent, then transfected with an equal amount
of reporter plasmid (1.6 mg) and 0.32 mg of pRL-CMV (Promega)
as transfection efficiency control, using lipofectamine 2000
(Invitrogen) and following the manufacturer’s indications. Five
hours later, serum-free DNA-containing medium was replaced by
fresh growth medium and the cells were harvested 48h after
transfection. Luciferase assays were performed as described (Dual-
Luciferase Reporter Assay System, Promega). All assays were
carried out in triplicate and performed twice for confirmation.
RNA analysis
Total RNA was prepared from exponentially growing cells using
RNeasy Mini Kit (Qiagen, Hilden, Germany). For Northern blot
analysis, RNA was electrophoresed in 1.5% formaldehyde-
denaturing agarose gel, with the 0.24–9.5 kb RNA Ladder
included in one lane as a size marker (Gibco BRL, Gaithersburg,
MD). RNA was then transferred onto Biodyne B membrane (Pall,
East Hills, NY) according to manufacturer’s recommendations and
fixed. The human p16
INK4a gene-coding region was used as probe
labeled with [a-
32P] dCTP (Yahui, Beijing, China) by random
priming using the Prime-a-Gene Labeling System (Promega).
Hybridization was carried out in ExpressHyb
TM Hybridization
Solution (Clontech) at 68uC for 1 h. The blot was stringently washed
with 0.16SSC, 0.1% SDS at 68uC for 15 min twice. Autoradiog-
raphy was performed at 280uC. The same blot was stripped after
probing and then reprobed with the
32P-labeled GAPDH probe to
control for equivalent RNA loading in each lane.
Western blot
Cell extracts were prepared following standard procedures. Briefly,
three to five volumes of lysis buffer (50 mM Tris-HCL, pH 7.4,
0.25 M NaCl, 0.1% Triton-X-100, 1 mM EDTA, 50 mM NaF,
1 mM DTT, 0.1 mM Na3VO4) were added to a cell pellet. The
following protease inhibitors were added: 0.1 mM PMSF, 1 mg/
ml leupeptin, 1 mg/ml aprotinin). After incubation on ice for
30 min, samples were centrifuged at 14,000 r.p.m. for 5 min at
4uC to recover the supernatant. After proteins were electrophor-
esed in a 15% (for p16) or 8% (for Sp1/Sp3) denaturing polyacyl-
amide gel and transferred to a PVDF membrane, the membrane
was blocked in 5% nonfat milk-TBS-0.25% Tween 20 for 1 h
and incubated with the primary antibody in TBS-0.25% Tween
20 for 1 h at room temperature. Complexes were detected with
horseradish peroxidase-linked secondary antibody and enhanced
chemiluminescence (SuperSignal, Pierce). The primary and
secondary antibodies used in this study were all from Santa Cruz
Biotechnology (Santa Cruz).
Preparation of nuclear extracts
Nuclear extracts from 2BS cells were prepared as follows: About
1610
6 cells were harvested, washed twice with cold PBS (phosphate-
buffered saline) and collected by centrifugation at 3500 rpm at 4uC
for 5 min. The cells were resuspended in 400 mlo fs o l u t i o nI
(10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2,0 . 1m M
EDTA, 0.1 mM DTT, 0.5 mM PMSF) and lysed by passing them
through a 25 gauge syringe. Nuclei were pelleted at 2,000 r.p.m for
10 min, washed once with solution I and resuspended in 200 mlo f
solution II (solution I with 5% glycerol, 400 mM NaCl and without
KCl). The suspension was rotated at 4uC for 30 min and then
centrifuged at 14,000 r.p.m, 4uC, for 30 min. The resulting clear
supernatant was stored at 280uCu n t i lu s e .
Electrophoretic mobility shift Assay (EMSA) and
supershift assay
A 38 bp long oligonucleotide 59-GGAAGGAAACGGGGCGG-
GGGCGGATTTCTTTTTAACAG-39 (oligo I) extending from
nt 2474 to 2437 or a 28 bp long oligonucleotide 59-CAGAGGG-
TGGGGCGGACCGAGT GCGCTC-39 (oligo II) extending
from nt 276 to 249 on the 59 UTR of p16 gene, was used in
EMSA and supershift assay. Double stranded DNA fragments
were end-labeled with [c-
32P] dATP (Yahui, Beijing, China) and
T4 polynucleotide kinase (New England Biolabs, Beverly, MA).
The probes were purified using QIAquick Nucleotide Removal
Kit (Qiagen) and 15,000 cpm were incubated for 25 min on ice
with 10 mg of nuclear extract from 2BS cell line, in the presence of
20 mM Tris-HCl pH 7.5, 75 mM KCl, 3.5 mM DTT, 20 nM
ZnCl2,1 mg/ml BSA, 5% glycerol and 1 mg poly (dI-dC)
(Pharmacia Biotech, Piscataway, NJ) in a total volume of 20 ml.
Table 1. Serial mutagenesis of GC-box in the 59-flanking regions of the human p16
INK4a.
..................................................................................................................................................
GC-box/probe Position Sequence
GC-I 2474–2447 Wild type: 59-GGAAGGAAACGGGGCGGGGGCGGATTTC-39
Mut 1: 59-GGAAGGAAACGGATCCGGGGCGGATTTC-39
GC- II 2462–2435 Wild type: 59-GGCGGGGGCGGATTTCTTTTTAACAGAG-39
Mut 2: 59-GGCGGGGGCAGATCTCTTTTTAACAGAG-39
GC-III 2380–2355 Wild type: 59-GGGAGGCCGGAGGGCGGTGTGGGGGG-39
Mut 3: 59-GGGAGGCCGGATCCCGGTGTGGGGGG-39
GC-IV 276–249 Wild type: 59-CAGAGGGTGGGGCGGACCGAGTGCGCTC-39
Mut 4: 59-CAGAGGGTGGGGGGATCCGAGTGCGCTC-39
GC-V 226–21 Wild type: 59-GCAGGCAGCGGGCGGCGGGGAGCAGC-39
Mut 5: 59-GCAGGCAGCGGGATCCGGGGAGCAGC-39
doi:10.1371/journal.pone.0000164.t001
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PLoS ONE | www.plosone.org 2 January 2007 | Issue 1 | e164For supershift experiments, 2 mg of antibody against Sp1 or Sp3
(Santa Cruz Biotechnology, Santa Cruz, CA) was incubated for
20 min on ice with the nuclear extract before adding the labeled
probe. DNA/protein complexes were separated from free DNA on
a 5% polyacrylamide gel in TBE (89 mM Tris, 89 mM boric acid,
2 mM EDTA) at 4uC for 120 min at 340 V. After electrophoresis,
gels were dried and autoradiographed.
Chromatin immunoprecipitation (ChIP)
ChIPs were performed using the Chromatin Immunoprecipitation
Assay Kit (Upstate, New York) according to manufacturer’s
instruction. In brief, 1610
6 cells were crosslinked by adding
formaldehyde directly to cell culture media and incubated for
10 min at 37uC. Wash cells twice with cold PBS and then cells
were scraped and resuspended in 200 ml of SDS Lysis Buffer.
Chromatin was then sonicated to an average length of 0.5 Kb for
three 30 sec. pulses at maximum power. Chromatin extracts were
diluted 10 folds in Dilution Buffer and preincubated for 30 min at
4uC with 80 ml of Salmon Sperm DNA/ protein A Agarose.
Twenty microlitres of diluted supernatant was kept for isolation of
input DNA and to quantitate the DNA in different samples. After
pelleting agarose by brief centrifugation, 2 mg of anti-Sp1
antiserum (test group) or 2 mgo fb-actin antibody (irrelevant
antibody control) was added to the supernatant fraction and
incubated overnight at 4uC with rotation. In addition, perform
a no antibody immunoprecipitation by incubating the supernatant
fraction with Salmon Sperm DNA/ protein A Agarose for 1 h at
4uC. Add 60 ml of Salmon Sperm DNA/ protein A Agarose for
1 h at 4uC to collect the antibody/antigen-DNA complex. The
chromatin bound to the protein A Agarose beads was eluted in
500 ml of freshly prepared elution buffer (1% SDS, 0.1 M
NaHCO3). After reversing crosslinks, the samples were deprotei-
nized and phenol-chloroform extracted, then DNA was ethanol
precipitated using yeast tRNA as a carrier. Pellets were
resuspended in 50 ml of TE buffer for PCR analysis.
Each PCR reaction mixture contained 5 ml of immunoprecipi-
tated chromatin in a final reaction volume of 20 ml. PCR mixtures
were amplified for 35 cycles of 94uC for 30 s, 54uC for 30 s, and
72uC for 30 s. To amplify GC-box containing regions of p16
INK4a
promoter, the sequences of the primers used were as follows:
ChIP1, 59-CCCCGATTCAATTTGGCAGTTAGG-39 (2505–
2491); ChIP2, 59-CAGCGTTGGCAAGGAAGGAG GAC-39
(2342–2318). All primers were synthesized at AuGCT Bio-
technology Co., Ltd (Beijing, China).
RNA interference(RNAi)
The target sequence against mRNA of Sp1 is 59-AUCACUCCA-
UGGAUGAAAUGATT-39, which has been reported to be effective
in some cell lines [30]. The hairpin siRNA(small interference RNA)
template oligonucleotides containing the target sequence is designed
following pSilencer neo instruction manual (Ambion, USA), and was
chemically synthesized, annealed and inserted into the BamH I and
Hind III site of pSilencer U6 2.1 neo vector (Ambion, USA).
Cells were transfected using Lipofectamin 2000 as specified by
the manufacturer. The transfection mixture was left on the cells for
4 h, after which DMEM/20% serum without antibiotics was
added. For efficient knockdown two more transfections were
performed at 24 h and 48 h after the first transfection.
SA-b-Galactosidase activity at pH 6.0
Cells were washed twice in PBS, fixed in 3% formaldehyde, and
washed again in PBS. The cells were incubated overnight at 37uC
(without CO2) with freshly prepared SA-b-Gal staining solution.
RESULTS
GC boxes are essential for p16
INK4a promoter activity
in senescent human fibroblast cells
To determine the crucial GC-rich region of the human p16
INK4a
promoter, plasmid pGL3-620 that contained the p16
INK4a pro-
moter with 620 bp upstream of the translation start site was used
to generate GC boxes site mutation constructs pGL-Mut 1,5
(Tab. 1, and Fig. 1A) respectively. These plasmids were then
individually transfected into young (Fig. 1B) or senescent (Fig. 1C)
human embryonic lung fibroblasts 2BS cells, and the promoter
activities were measured by luciferase activities. Results showed
that both in young and senescent cells, the mutation of GC-I, II
or GC-IV reduced the promoter activity, while the mutation of
GC-III or GC-V had less significant effect. What’more, the effect
is stronger in the senescent cells than in the young ones. Therefore,
GC-I, II and GC-IV, especially GC-II, are the key sites of action
for Sp1 induced p16
INK4a expression. Furthermore, compared the
relative value of these groups, it appears that the promoter activity
of the human p16
INK4a is much more potent in senescent cells than
in young ones.
Senescent cells contain potent Sp1/Sp3 binding
activities to the GC boxes of the p16
INK4a promoter
To evaluate whether Sp proteins indeed binds to the GC boxes,
gel electrophoretic mobility shift assays (EMSA) were performed.
Oligo I including GC-I and GC-II and oligo II containing GC-IV
were 59end labeled with [c-
32P-]dATP and incubated with nuclear
extracts from either young or senescent 2BS cells. The DNA-
protein binding complexes were then analyzed on 5% polyacryl-
amide gel. As shown in Figure 2A, three specific DNA-protein
binding complexes a, b and c, were detected by using oligo I, and
all of the complexes disappeared with the addition of 100-fold
molar excess of unlabeled competitor. To confirm the presence of
Sp proteins in these complexes, Sp1 monoclonal antibodies or Sp3
polyclonal antibodies were incubated with the nuclear extracts
before the DNA-protein binding complexes being analyzed on
the gel. As shown in Figure 2A, complex a disappeared with the
addition of Sp1-specific antibody; while complex b and c
disappeared by using Sp3-specific antibody. Similar results were
obtained with radio-labeled oligo II as probes, as demonstrated in
Figure 2B. What is also worth noting is that Sp1/Sp3 DNA
binding affinity in senescent cells is about 78% higher than that in
young ones. This result is consistent with our earlier observation
(Fig. 1) that the p16
INK4a promoter had much potent activity in
senescent cells than that of young ones.
Sp1/Sp3 binds to p16
INK4a promoter in vivo
We next want to know whether Sp1 and/or Sp3 could bind to
p16
INK4a promoter in living 2BS cells. For this purpose, we
performed ChIP assay to monitor Sp1- and Sp3-occupancies in
the p16
INK4a promoter using gene specific primers. Consistent with
the results of EMSA, ChIP assays showed that Sp1/Sp3 indeed
bound to p16
INK4a promoter in vivo and the binding activity in
senescent cells was higher than in that of young cells by nearly 5
folds (Sp1) and 3.5 folds (Sp3) respectively (Fig. 3A, Fig. 3B).
Sp1 induces p16
INK4a promoter activation and both
Sp1 binding and basal level of Sp1 are critical to the
expression of p16
INK4a
To analyze the effect of Sp1 and Sp3 on p16
INK4a promoter, Sp1
and/or Sp3 expression vectors were co-transfected with pGL3-620
Sp1 Promotes p16 during Aging
PLoS ONE | www.plosone.org 3 January 2007 | Issue 1 | e164into young or senescent 2BS cells. As determined by luciferase
activity, Sp1 activated the p16
INK4a promoter in a dose-dependent
manner in both young and senescent 2BS cells, while Sp3 had little
effect on it (Fig. 4).
To confirm the effect of Sp1 on p16
INK4a promoter activity,
mithramycin (MTR), which specifically blocks Sp1 and Sp3
binding to GC boxes, was added to 2BS cells after transfection
with pGL3-620. As expected, the p16
INK4a promoter activity was
inhibited by MTR in a dose-dependent manner in both young
(Fig. 5A) and senescent (Fig. 5B) 2BS cells. Further, the p16
INK4a
expression was also reduced at mRNA (Fig. 6A) and protein
(Fig. 6B) levels in 2BS cells, by 66% (mRNA level) and 48%
(protein level) respectively, in the senescence group with 24 hours
of MTR treatment.
As the mechanism of MTR treatment is blocking the
transcription factors such as Sp family binding to GC-box, in this
way, MTR could also affect the binding of other transcriptional
factors to p16
INK4a promoter. To investigate the role of Sp1
Figure 2. Binding of Sp1 and Sp3 to the p16
INK4a promotor. Electrophoretic mobility shift assays (EMSA) was performed using nuclear extracts (NE)
from young (Y) or senescent (S) 2BS cells and radiolabeled oligo I (A) or oligo II (B). Competition was performed in the presence of 100-fold molar
excess of the cold synthetic oligos (Comp) as indicated. The major specific complexes are indicated as a, b and c. The presence of Sp1 and Sp3 in the
DNA-protein complexes was monitored by the disappearance of the retarded bands in the presence of antibodies against Sp1 and Sp3 (supershift).
doi:10.1371/journal.pone.0000164.g002
Figure 1. p16
INK4a transcription activity increased with cell senescence. A. Schematic presentation of mutants of GC-boxes in the p16
INK4a
promoter. Young (B) and senescent (C) 2BS cells were transfected with 1.6 mg GC-box mutants or pGL3-620 along with 0.32 mg pRL-CMV vectors.
48 hours after transfection, cells were harvested and subjected to luciferase activity assays. The luciferase activity was normalized to Renilla luciferase
activity. The data represent the mean.6S.E. of three independent experiments.
doi:10.1371/journal.pone.0000164.g001
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Sp1 binding to GC boxes is essential for the transcription of
p16
INK4a (Fig. 7A). Western Blot showed that si-Sp1 remarkably
reduced the expression of Sp1, which in turn lead to a reduction of
p16
INK4a expression (Fig. 7B).
The results from two aspects mentioned above suggest that not
only Sp1 can activate p16
INK4a promoter in vivo but is required in
maintenance of normal level of p16
INK4a protein in cultured
human fibroblasts.
The binding affinity to p16
INK4a promoter is the key
event but not the quantity of Sp1 enhanced during
the aging process
The results mentioned above demonstrate that during the cell
aging process, Sp1 contributes to the higher expression of p16
INK4a.
However, which is responsible for this contribution: the quantity of
the Sp1 expression or the binding affinity to p16
INK4a promoter?
To elucidate this confusing problem, western analyses were
performed using nuclear proteins from young and senescent 2BS
cells. The results showed that the quantity of Sp1 and Sp3 proteins
does not increase in the senescent cells. In another words, it
contains the same amount of Sp1 and Sp3 proteins as that of
young cells (Fig. 8). Combined with the results observed in EMSA
and ChIP assays, we thus conclude that the increased binding
must be due to the increase of Sp1 DNA binding affinity, which in
turn lead to the higher expression of p16
INK4a in senescent cells.
Sp1 increases SA-b-Gal activity whereas si-Sp1
expression inhibits SA-b-Gal activity
SA-b–galactosidase staining is a common marker for cellular
senescence. Usually, the b-galactosidase activity increases with the
cell PD(population doubling) accumulating. The biological effect
of over-expression (by Sp1 expression plasmid transfection) or
knockdown (by RNAi approach) of Sp1 in 2BS cells were further
evaluated by this method. The results showed that Sp1-over-
expressed cells were strongly stained blue versus the control.
However, there were only a few dispersed cells that were SA-b-
Gal-stained in the Sp1 knocked-down cells (Fig. 9). All these
outcomes manifested that RNAi-mediated silencing of Sp1 gene
could delay senescence accompanied with decreased p16
INK4a
levels, however, over-expression of Sp1 could increase the p16
INK4a
Figure 3. Sp1/Sp3 bound to the GC boxes containing region in the
p16
INK4a gene promoter in 2BS cells. A and B. ChIPs assays of young (Y:
PD27) and senescent (S: PD60) 2BS cells using antibodies against Sp1
(A) or Sp3 (B), antibody against b-actin was used as irrelevant control
(Nc). (C) Senescent (S: PD60) 2BS cells were treated with MTR in the
dosage indicated, 24 hours later, cells were harvested and subjected to
ChIP assays. Data are representative of three independent experiments.
doi:10.1371/journal.pone.0000164.g003
Figure 4. Effect of Sp1 and Sp3 on p16
INK4a promoter activity. The reporter construct pGL3-620 was co-transfected with pCMV-Sp1 or/and pCMV-
Sp3 or control vector along with pRL-CMV in young (A) and senescent (B) 2BS cells. Luciferase assays were performed and normalized to the Renilla
luciferase activity. The mean6S.E. from three independent experiments was used to express the relative luciferase activity.
doi:10.1371/journal.pone.0000164.g004
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INK4a gene promoter. Young (A) and senescent (B) 2BS cells were transfected with
pGL3-620. 24 hours after transfection, cells were exposed to different dosage of MTR (M-A) as indicated for 24 more hours and subjected to luciferase
activity assays. The data represent the means6S.E. of five independent experiments.
doi:10.1371/journal.pone.0000164.g005
Figure 6. Expressions of p16
INK4a mRNA and protein are inhibited by
MTR treatment. Young (Y) and senescent (S) 2BS cells were either
treated with 100 nM MTR (MTR) for 24 hr or left untreated, total RNA
and protein were prepared and subjected to analyze the expression of
indicated genes by Northern blotting (A) and Western blotting (B),
respectively.
doi:10.1371/journal.pone.0000164.g006
Figure 7. Knock-down of Sp1 reduces expression of endogenous
p16
INK4a. Following transfection of 2BS cells with si-Sp1 or a control
plasmid, RT-PCR (A) and Western blotting (B) were carried out to
analyze the expression of the genes indicated.
doi:10.1371/journal.pone.0000164.g007
Figure 8. Expression of Sp1 and Sp3 in young and senescent 2BS
cells. Western blot analysis of Sp1 and Sp3 expression in young (Y) and
senescent (S) 2BS cells, data are representative of three independent
experiments.
doi:10.1371/journal.pone.0000164.g008
Figure 9. Influence of Sp1 levels on SA-b-Gal activity. 2BS/pCMV (A),
2BS/ pCMV-Sp1 (B), 2BS/pSliencer (C), 2BS/si-Sp1 (D), (all above at PD
40), untransfected young (PD 27) (E), middle-aged (PD 48) (F), and
senescent (PD 56) (G) 2BS cells were cultured and then stained to assess
SA-b-Gal activity.
doi:10.1371/journal.pone.0000164.g009
Sp1 Promotes p16 during Aging
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cells.
DISCUSSION
p16
INK4a, a tumor suppressor gene that inhibits cyclin-dependent
kinase 4 and cyclin-dependent kinase 6, has also been implicated
in the mechanisms underlying replicative senescence. Many
transcription factors are involved in transcriptional regulation via
the corresponding elements distributed in the promoter region of
p16
INK4a. What should be emphasized is that the character of
p16
INK4a promoter is GC-rich rather than the common element
such as TATA box. In addition, GC-rich boxes represent putative
target sites for binding of Sp1 and Sp3 transcription factors [29].
In this study, we established the importance of transcription
factor Sp1 on the regulation of p16
INK4a gene expression from the
different aspects and different strategies during aging in human
embryonic lung fibroblasts, 2BS cells. Among the five GC boxes
within the region of 620 bp upstream of the translation start site,
the contribution of these five elements to p16
INK4a transcription is
not equal, GC-I, II and IV is more important rather than GC-III
and V by mutagenesis analyses, especially GC-II is the most crucial
element to the p16
INK4a promoter activity, since its mutation
abolished p16
INK4a gene transcription in senescent cells. What’s
more, the effect on the promoter activity in senescent cells is more
significant than inyoung cells. All results mentioned above suggested
that GC boxes are more instrumental to p16
INK4a gene expression
coupled with aging process and it is the first time to investigate the
roles of GC-boxes distributed in p16
INK4a promoter and the
relationship between these elements and transcription activity of
the target gene meticulously and systemically during aging.
Protein binding studies identified Sp1 and Sp3 as the major
components of the complexes formed between the nuclear extracts
and the oligos containing GC box. Although we cannot preclude
involvement of other factors, the Sp1 and Sp3 antibodies blocked
each of the specific complexes in vivo and in vitro. Sp1 is a widely
studied transcription factor that can bind to and act through
the GC boxes. Although it is generally believed that Sp1 is
ubiquitously expressed, Sp1 gene expression can show up to 100-
fold differences in different cell types and at different stages of
development in mouse [30]. While Sp3 is found to be highly
homologous to Sp1 with similar affinities for GC and GT boxes,
there are some striking functional differences between them. In
some cell lines, it can activate transcription [31]. However, under
other circumstances Sp3 is only weakly active, and in some cases,
Sp3 can repress transcription driven by Sp1 or other transcription
factors [32]. To investigate the transcription activities of Sp1 and/
or Sp3 on p16
INK4a promoter, we co-transfected Sp1 and/or Sp3
expression vectors with pGL3-620 into young and senescent 2BS
cells and performed the luciferase assays. The results showed that
Sp1 induced the p16
INK4a promoter activity, while Sp3 had little
effect. The induction of promoter activity was not as potent as we
would expect, which might be due to the high levels of endogenous
Sp1 expression and the lower transfection efficiencies of 2BS cells
(The same experiments in HeLa cells showed the more evident
change, data was not shown). To further prove the effect of Sp1 on
p16
INK4a expression, two strategies in different way were used:
MTR, an inhibitor of Sp1/Sp3 binding, and siRNA, the inhibitor
of Sp1 expression. The results which reduced the p16
INK4a
promoter activity and its expression both in mRNA level and
protein level suggest again that Sp1 is both necessary and sufficient
for the induction of p16
INK4a gene expression in 2BS cells.
It has been documented that the expression of p16
INK4a
increased in senescent human fibroblast cells owing to the
regulation of various of transcription factors in previous and our
former work , such as E47, Id1, Jun B and RREB etc.[18,20–
22,25]. In this study, both EMSA and ChIP assays showed that
senescent cell nuclear extracts contained higher Sp1/Sp3 binding
activities to the p16
INK4a promoter. Taken together the results that
mutation of GC boxes had more detrimental effect on the p16
INK4a
promoter in senescent cells and knock-down of Sp1 by siRNA
down-regulate the expression of p16
INK4a, we postulate that Sp1
transcriptional activity, including the binding activity to the GC
boxes of p16
INK4a promoter, is enhanced in senescent cells, which
in turn plays a role in the elevated p16
INK4a gene expression during
senescence. It is applied a reasonable interpretation for the
observation of much more potent promoter activities for p16
INK4a
in senescent cells.
In addition, though Sp1 is considered to be a constitutive
transcription factor, Sp1 protein levels can vary significantly in
different tissues. To test whether increased Sp1 binding is a result
of induced Sp1 expression in senescent cells, we performed
Western analyses. The results showed that the protein levels of Sp1
and Sp3 did not change significantly between young and senescent
2BS cells. So the increased binding observed in the senescent cells
is likely the result of the augmentation of Sp1 and/or Sp3 binding
affinity. On the other hand, the result of RNAi transfection
demonstrated that although it need not increase Sp1 expression,
however, a basal level is necessary for p16
INK4a expression. Once
it is lower than certain level, the expression of p16
INK4a is also
weakened.
The alteration of Sp1 activity during senescence may result
from different post-translational modification or transcriptional
co-factor. The two major types of modification that are thought to
be involved in transcription regulation by Sp1 are glycosylation
and phosphorylation. O-glycosylation of Sp1 with N-acetylgluco-
samine has been linked to multiple changes in Sp1 function,
including altered self-association, altered interaction with basal
transcription factors and modulation of its degradation [33,34],
but not its DNA binding activity [35], while phosphorylation has
been found to either decrease [36] or increase [37] the DNA
binding activity. Finally, earlier studies have shown that histone
deacetylase 1 (HDAC1) binds to Sp1 and represses its transcription
activity [38]. Sp1 may serve as a scaffold to recruit HDAC to the
promoter, which causes chromatin condensation leading to
transcription repression. Since the level of HDAC1 has been
found to decrease significantly in senescent human fibroblasts [39],
which may result in the release of Sp1, we postulate that more
active Sp1 would be available for transcription activation.
All in all, among the multitudinous transcription factors, Sp1 is
also an important and essential member for the transcription and
expression of p16
INK4a, whereas, in another aspect, GC box
distributed in the promoter of p16
INK4a, especially GC- II is also
the key element for both the expression of p16
INK4a and binding
with Sp1. Only both of them interact properly, do the gene
expression and cell physiology act in the normal program.
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